{
    "version": "https://jsonfeed.org/version/1.1",
    "title": "Harvard Health Posts by Kathryn Rexrode, MD, MPH Feed",
    "home_page_url": "https://www.health.harvard.edu/authors/kathryn-rexrode-md-mph",
    "feed_url": "https://www.health.harvard.edu/authors/kathryn-rexrode-md-mph/feed/json",
    "language": "en-US",
    "icon": "https://www.health.harvard.edu/img/logos/hhp-logo-mark-lg.jpg",
    "items": [{
            "id": "https://www.health.harvard.edu/blog/more-intensive-treatment-of-dcis-reduces-the-risk-of-invasive-breast-cancer-2021011921764",
            "title": "More intensive treatment of DCIS reduces the risk of invasive breast cancer",
            "url": "https://www.health.harvard.edu/blog/more-intensive-treatment-of-dcis-reduces-the-risk-of-invasive-breast-cancer-2021011921764",
            "content_html": "With increased rates of diagnosis of very early breast cancer known as ductal carcinoma in situ, there has been controversy about treatment. A recent study found that having DCIS was likely to lead to invasive breast cancer later, and also that women who chose more intensive treatment early were less likely to have invasive breast cancer.",
            "summary": "With increased rates of diagnosis of very early breast cancer known as ductal carcinoma in situ, there has been controversy about treatment. A recent study found that having DCIS was likely to lead to invasive breast cancer later, and also that women who chose more intensive treatment early were less likely to have invasive breast cancer.",
            "date_published": "2021-01-21T00:00:00-05:00",
            "date_modified": "2021-01-21T00:00:00-05:00",
                        "authors": [                { "name": "Kathryn Rexrode, MD, MPH" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/10395/conversions/GettyImages-1033239842-thumb.jpg",

            "tags": [ "Women's Health" ]
        }        
    ]
}